Mefloquine to prevent malaria: A systematic review of trials

British Medical Journal

Volumn 315, Issue 7120, 1997, Pages 1412-1416

  Croft, Ashley ^a   Garner, Paul ^b  

^a Ministry of Defencc   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; MEFLOQUINE; PLACEBO;

ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MEDICAL INFORMATION; MEDICAL LITERATURE; META ANALYSIS; PRIORITY JOURNAL; SIDE EFFECT; TRAVEL;

EID: 0030726744     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7120.1412     Document Type: Article

References (54)

1. Centers for Disease Control. Health information for international travel. Atlanta: US Department of Health and Human Services, 1994.
2. Commonwealth Department of Human Services and Health. Health information fur international trawl. Canberra: CDHSH, 1995.
3. World Health Organisation. International travel and health, Vaccination requirements and health advice. Geneva: WHO Office of Information, 1995.
4. Ingnun?? RJ H, Ellis-Pegler RB. Health advice for overseas travellers. Wellington: Ministry of Health, 1996.
5. Inspectie voor de Gezondheidszorg. Malariaprophylaxis. Rijswijk: Inspectie voor de Gezondheidszorg, 1996.
6. Bradley DJ, Warhurst DC. Guidelines for the prevention of malaria in travellers from the United Kingdom. Commun Dis Rep CDR Rev 1997;7:R137-52.
7. Hollyoak V. Prophylaxis against malaria. BMJ 1995;310:1329.
8. Evans MR. Adverse events associated with mefloquine. Patients may start to take cheaper over the counter regimens. BMJ 1996;313:1554.
9. Steffen R, Fuchs E, Schildknecht J, Naef U, Funk M, Schlagehauf, et al. Mefloquine compared with other malaria chemoprophylactic regimens in lourists visiting east Africa. Lancet 1993;341:1299-303.
10. Lobel HO, Miani M.Eng T, Bernard KW, Hightower AW, Campbell CC. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993;341:848-51.
11. Corominas N, Gascón J, Mejias T, Caparrrós F, Quintó L, Codina C, et al. Reacciones adversas asociadas a la quimioprofilaxis antipalúdica. Med Clin(Barc) 1997;108;772-5.
12. Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combinations of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ 1996;313:525-8.
13. Corbett EL, Doherty JF, Behrens RH. Study in returned travellers confirms authors' findings. BMJ 1996;313:1552.
14. Van Riemsdijk MM, van der Klauw MM, van Heest JAC, Reedeker FR, Ligthelm RJ, Herings RMC, et al. Neuro-psychiatric effects of antimalaiials. Fur J Clin Pharmacol 1997;52:1-6.
15. Cook GC. Mefloquine toxicity should limit its use to treatment alone. BMJ 1995;311:190-1.
16. Perry IC. Malaria prophylaxis. BMJ 1995;310:1673.
17. Cochrane Collaboration handlbook. Oxford: Cochrane Collaboration, 1997. Updated annually.
18. Croft AMJ, Garner P Mefloquine malaria prophylaxis. In: Garner P, Gelband H, Olliaro P, Salinas R, Volmink |J, Wilkinson D, eds. Infectious diseases module. Cochrane Library [database on disk and CD ROM), Oxford: Update Software, October 1997. Updated quarterly.
19. Arthur JD.Echeverria P, Shanks GD, Karwacki J, Bodhidatta L, Brown JE. A comparative study of gastrointestinal infections in United States soldiers receiving doxycycline or mefloquine for malaria chemoprophylaxis. Am J Trop Med Hyg 1990;43:608-13.
20. Arthur JD, Shanks GD, Echeverria P. Mefloquine prophylaxis. Lancet 1990;i:972.
21. Boudreau F, Schuster B, Sanchez J, Novakowski W, Johnson R, Redmond D, et al. Tolerability of prophylactic Lariam regimens. Trop Med Parasitol 1993;44:257-65.
22. Croft AMJ, Clayton TC, World MJ. Side effects of mefloquine prophylaxis for malaria: an independent randomized controlled trial. 'Irans R Soc Trop Med Hyg 1997;91:199-203.
23. Croft AMJ. Toxicity of melloquine is similar to that of other chernoprophylaxis. HMJ 1995;311:191.
24. Croft AMJ, Williams G, Docherty MJ. Mefloquine prophylaxis in British troops in Kenya: a follow-up, independent randomized controlled trial. Unpublished.
25. Croft AMJ, World MJ. Neuropsychiatric reactions with inefloquine chemoprophylaxis. Lancet 1996;347:326.
26. 15
27. Kollaritsch H, Que JU, Kunz C, Wiedermann G, Herzog C, Cryz SJ. Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine. J Infect Dis 1997; 175:871-5.
28. Macpherson D, Gamble K, Tessier D, Keystone J, Streiner D. Mefloquine tolerance: a randomized, double-blinded, placebo-controlled study using a loadig dose of mefloquine in pre-exposed travellers. Presented at the Fifth International Conference on Travel Medicine, Geneva, 1997 March 26. Abstract Number 220.
29. Ohrt C, Richie TL, Widjaja H, Shanks GD, Fitriadi J, Fryauff DJ, et al. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann Intern Med l997;126:963-72.
30. Schlagenhauf P, Lobel H, Steffen R Johnson R, Popp K, Tschopp A, et al. Tolerance of mefloquine by Swissair trainee pilots. Am J Trop Med Hyg 1997;56:235-40.
31. Vuurman EFPM, Muntjewerff ND, Uiterwijk MMC, van Veggel LMA, Crevoisier C, Haglund L, et al. Effects of mefloquine alone and with alcohol on psychomotor and driving performance. Eur J Clin Pharmacol 1996;50:475-82.
32. Held TK, Weinke T, Mansmann U, Trauimann M, Pohle HD. Malaria prophylaxis: identifying risk groups tor non-compliance. Q J Med 1994;87:l7-22.
33. Greenhalgh T Papers that report drug trials. BMJ 1997;315:480-3.
34. Huzly D, Schonfeld G, Beurle W, Bienzle U. Malaria chemoprophylaxis in German tourists: it prospective study on compliance and adverse reactions. J Travel Med 1996;3:148-55.
35. Bern L, Kerr L, Stuerchler D. Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions. J Trop Med Hyg 1992;95: 167-79.
36. Phillips MA, Kass RB. User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis. J Travel Med 1996;3:40-5.
37. Schlagenhauf P, Steffen R, Lobel H, Johnson RF, Letz R, Tschopp A, et al. Mefloquine tolerability in chemoprophylaxis: focus on adverse event assessment, stereochemistry and compliance. Trop Med hit Health 1996; 1:485-94.
38. Ter Kuile FO, Nosten F.Thieren M, Luxemburger G, Fdstein MD, Chongsuphajaisiddhi T, et al. High-dose mefloquine in the treatment of multidrug-resistant falciprurm malaria. J Infect Dis 1992; 166:1393-400.
39. Meszaros K, Acute psychosis caused by mefloquine prophylaxis? Can J Psychiatry 1996;41:196.
40. Handschin J, Crevoisier G, Sturchler D. Mefloquine in malaria prophylaxis: low efficacy or low compliance? Lancet 1995;346:1294.
41. Woolf SH. Practice guidelines - a new reality in medicine. II: Methods of developing guidelines. Arch Intern Med 1992; 152:946-52.
42. Grimshaw JM, Eccles MP, Russell IT. Developing clinically valid practice guidelines. J Eval Clin Pract 1995;1:37-48.
43. Royal College of General Practitioners. The development and implementation of clinical guidelines: report of the Clinical Guidelines Working Group. Report from general practice paper 26. London: RCGP, 1995.
44. Eccles MP, Glapp Z, Grimshaw J, Adams PC, Higgins B, Purves I, et al. Developing valid guidelines: methodological and procedural issues from the north of England evidence based guideline development project. Quol Health Care 1996;5:44-50.
45. West E, Newton J. Clinical guidelines. RMJ 1997;315:324.
46. Scott M, Marinker ML. Small group work. In: Marinker ML, ed. Medicine audit and general practice. London: BMJ, 1990:180-95.
47. Woolf SH, DiGuiscppi C, Atkins D, Kamerow DB. Developing evidencebased clinical practice guidelines: lessons learned by the US Preventive" Services Task Force. Annu Rev Public Health 1996; 17:511-38.
48. Jacobson LD, Kdwards GK, Granier SK, Butler CC. Evidence-based medicine and general practice. Br J Gen Pract 1997;47:449-52.
49. Liberati A. Consumer participation in research and heallh care. BMJ 1997;315:499.
50. Smith PG, Morrow RH. field trials of health interventions in developing countries: a toolbox. London: Macmillan Educational, 1996:44.
51. MacLean M, Anderson J, Davies C. Making malaria research bite. Nat Med 1997;3:l4-6.
52. Altman DG. Better reporting of randomised controlled trials: the CONSORT statement BMJ 1996;313:570-1.
53. Begg C, Gho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276:637-9.
54. Schulz KF. Randomised trials, human nature, and reporting guidelines. Lancet 1996;348:596-8.